-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 20/12/24 )
NAV
₹40.79
Last change
₹-0.42 -0.01%
Fund Size (AUM)
3248.80 Cr
Performance
30.74% (5Y)
Fund Details
DSP Healthcare Fund Regular Growth
as of 20/12/24
AUM
3248.80 Cr
Expense Ratio
1.92 %
Benchmark
BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Chirag Dagli
Exit Load
0.5% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | 42.48% | 23.06% | 30.74% |
| BSE Healthcare TR INR | 43.76% | 19.63% | 26.27% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
10.28% |
Suven Pharmaceuticals Ltd |
10.01% |
Cipla Ltd |
7.86% |
Ipca Laboratories Ltd |
7.62% |
Alembic Pharmaceuticals Ltd |
4.79% |
Gland Pharma Ltd |
4.4% |
Apollo Hospitals Enterprise Ltd |
3.91% |
Concord Biotech Ltd |
3.82% |
Vijaya Diagnostic Centre Ltd |
3.66% |
Laurus Labs Ltd |
3.39% |
Sector Allocation
Healthcare |
98.55% |
Financial |
1.45% |
Asset Allocation
-
95%
Equity
-
5%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
30.29% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
27.43% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
30.74% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
27.39% (5Y)
-
